Searchable abstracts of presentations at key conferences in endocrinology

ea0094p294 | Thyroid | SFEBES2023

Development of a thyroid patient database in conjunction with the IT system development team at a DGH

Smurthwaite Hannah

In September 2021 the pathology department announced it would be going paperless, a change that resulted in endocrine monitoring being added to the trust risk register. To manage this risk several options were considered including the DAWN system used by rheumatology and systems used by other local hospitals. Unfortunately, none of these were viable options. Discussions were started with the IT systems development team about building a database for management of thyroid patien...

ea0086p169 | Adrenal and Cardiovascular | SFEBES2022

Adrenal Incidentaloma Service in a DGH; Role of an endocrine pharmacist

Smurthwaite Hannah , Mani Hamid

An endocrine specialist pharmacist has been running an adrenal incidentaloma clinic since September 2020. As of Jun-22 258 patients have been seen in clinic and managed using a local protocol. Adrenal incidentaloma patient referrals are screened as per current guidelines on receipt; those measuring <1 cm are declined, suspected adrenocortical carcinomas are seen by a consultant and referred elsewhere if needed. All others are seen by the endocrine pharmacist within 4 weeks...

ea0086p96 | Neuroendocrinology and Pituitary | SFEBES2022

A case of chronic hyponatremia secondary to SIADH treated with low dose Tolvaptan to prevent recurrent hospital admission and proven cost effective

Ahsan Masato , Smurthwaite Hannah , Mani Hamidreza

Introduction: Tolvaptan, a selective vasopressin 2 receptor antagonist is proving beneficial in managing hyponatremia secondary to SIADH.Case report: A 75-year-old male with history of traumatic SAH developed hyponatremia secondary to SIADH. He had multiple admissions with symptomatic hyponatremia. His sodium level kept dropping despite putting on fluid restriction and trial of sodium chloride tablets. He was started on Tolvaptan 7.5 once weekly initiall...

ea0086p141 | Thyroid | SFEBES2022

Are we following NICE guidelines in classifying hyperthyroid patients presenting to endocrinology clinic in a DGH?

Khalil Ghayyur , Ahsan Masato , Johnson Adam , Smurthwaite Hannah , Mani Hamidreza

Background: Nice guideline recommends using TSH receptor antibody as a tool for classification of hyperthyroid patients; and considering technetium scanning of the thyroid gland if TRAbs are negative. Early diagnosis of TED is also essential for treatment to be effective. The most common way to assess the severity of TED is to use the Clinical Activity Score (CAS) 7-point scale.Objectives: We aimed to evaluate if hyperthyroid patients are classified corr...

ea0065p37 | Adrenal and Cardiovascular | SFEBES2019

Group education clinics for patients with adrenal insufficiency; a DGH experience

Smurthwaite Hannah , Pierides Michael , Patel Kishor , Owen Lisa , Mani Hamidreza

Background: Adrenal crisis is a potentially life-threatening situation which can affect any patient with adrenal insufficiency (AI). Patients with AI and healthcare professionals looking after them should know the sick day rules and when and how to use parenteral hydrocortisone. Patient stories and feedback from patients with AI indicated low standards locally. We therefore aimed to empower patients through education and provide them with a hydrocortisone emergency kit.<p ...